Overview
Jaime Oteyza-De practices practicing medicine in Madrid, Spain.
Their clinical expertise encompasses Follicular Lymphoma, Hemolytic Transfusion Reaction, and Non-Hodgkin Lymphoma.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jaime Oteyza-De
Is Jaime Oteyza-De a top-rated expert for Follicular Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jaime Oteyza-De is classified as an Experienced expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jaime Oteyza-De participate in research or clinical trials?
Yes. Jaime Oteyza-De has published 10 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Jaime Oteyza-De's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Follicular LymphomaOteyza-De isExperienced. Learn about Follicular Lymphoma.
- Hemolytic Transfusion ReactionOteyza-De isExperienced. Learn about Hemolytic Transfusion Reaction.
- Non-Hodgkin LymphomaOteyza-De isExperienced. Learn about Non-Hodgkin Lymphoma.